Company: LIMN
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001410578-25-001746
Chunk: 189

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 189
---
 writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the ParentCo Common Stock outstanding immediately after giving effect to such exercise.

If the number of outstanding shares of ParentCo Common Stock is increased by a share capitalization payable in shares of ParentCo Common Stock, or by a split-up of common stock or other similar event, then, on the effective date of such share capitalization, split-up or similar event, the number of shares of ParentCo Common Stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of common stock. A rights offering to holders of common stock entitling holders to purchase ParentCo Common Stock at a price less than the fair market value will be deemed a share capitalization of a number of shares of ParentCo Common Stock equal to the product of (i) the number of shares of ParentCo Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for ParentCo Common Stock) multiplied by (ii) one (1) minus the quotient of (x) the price per share of ParentCo Common Stock paid in such rights offering and divided by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for shares of ParentCo Common Stock, in determining the price payable for ParentCo Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of shares of ParentCo Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the ParentCo Common Stock trades on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of ParentCo Common Stock on account of such ParentCo Common Stock (or other securities into which the warrants are convertible), other